Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

JPMorgan said Eli Lilly is enrolling about 500,000 new obesity drug patients per month, and maintains more than 60% share in ...

Eli Lilly and Company (NYSE:LLY) is one of the high-margin pharma stocks to buy now. Eli Lilly and Company (NYSE:LLY) is set ...

In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

Shares of Eli Lilly dropped about 14% within 15 minutes of market open, tumbling toward the worst daily percentage decline for the stock since the 31% loss suffered Aug. 9, 2000 and the third ...

Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. With ...

Eli Lilly shares tumbled Tuesday after the drugmaker lowered its revenue forecast for the 2024 fiscal year. ... Verve Therapeutics Stock Soars as Eli Lilly Buys Gene-Editing Firm for $1.3B.

While maintaining its revenue forecast of $58 billion to $61 billion, the company expects EPS of $20.78 and $22.28, down from $22.50 to $24 per share. ... Eli Lilly's stock isn't cheap.

Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and it's an element you can count on during any economic environment. This is because patients need their ...

Eli Lilly stock is trading near its all-time highs, with the shares only about 5% away from the record levels set in August. With the shares up nearly 68% in the past 52 weeks and 58.5% year-to ...

Eli Lilly & Co. shares fell 3.6% in pre-market trading on Thursday after the company reported second-quarter results that came in below Wall Street's forecast. The company's stock ended Wednesday ...